Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
format_facet:"Elektronische Ressource"
journalStr:"ClinicalTrials.gov"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22&filter%5B%5D=journalStr%3A%22ClinicalTrials.gov%22&lookfor=%22Arthritis%2C+Rheumatoid%22&type=Subject
/vufind/Search/Results?filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22&filter%5B%5D=journalStr%3A%22ClinicalTrials.gov%22&lookfor=%22Arthritis%2C+Rheumatoid%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22&filter%5B%5D=journalStr%3A%22ClinicalTrials.gov%22&lookfor=%22Arthritis%2C+Rheumatoid%22&type=Subject
PubPharm (2.444)
1
A Study to Assess Safety and Efficacy of ASP015K in Participants With Rheumatoid Arthritis (RA) Who Had an Inadequate Response or Intolerance to Methotrexate (MTX) : A Randomized, Double-Blind, Placebo-Controlled Confirmatory Study of the Safety and Efficacy of ASP015K in Patients With Rheumatoid Arthritis (RA) Who Had an Inadequate Response or Intolerance to MTX
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Novel PET Radioligands as Inflammatory Biomarkers in Rheumatoid Arthritis and Myositis : Evaluation of a Novel PET Radioligand as an Inflammatory Biomarker in Musculoskeletal Conditions
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis : A Phase 3b/4 Randomized, Double-Blind, Double Dummy, Active Comparator-Controlled Study, Comparing the Efficacy and Safety of Upadacitinib Versus Adalimumab in Subjects With Moderate to Severe Rheumatoid Arthritis on a Stable Background of MTX and Who Had an Inadequate Response or Intolerance to a Single TNF Inhibitor (SELECT- SWITCH)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
Developing a Screening Tool for Interstitial Lung Disease in People With Rheumatoid Arthritis Using Risk Factors : A Prospective, Multi-national, Cross-sectional Study on a Risk-factor Guided Approach to Interstitial Lung Disease Screening in Patients With Rheumatoid Arthritis at Higher Risk for ILD Using High Resolution Computed Tomography
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
Real World Use of Tocilizumab Biosimilar studY : A Multinational, Prospective, Non-interventional Study, to Assess Real World Use of a Tocilizumab Biosimilar in Rheumatoid Arthritis Patients
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Study To Assess Frequency Of Serious Infections In Clinical Practice In Japan For Adult Participants With Rheumatoid Arthritis Receiving Oral RINVOQ Tablets : Special Drug Use - Results Survey Of Evaluating Safety And Effectiveness Of RINVOQ In Patients With Rheumatoid Arthritis
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
Chronic Periodontitis and Tooth Loss in Patients With Rheumatoid Arthritis : Chronic Periodontitis and Tooth Loss in Patients With Rheumatoid Arthritis
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
Proximod Pharmacokinetics in Healthy Subjects and Patients With Rheumatoid Arthritis : A Single-center, Randomized, Double-blind, Placebo-controlled Phase Ib Study to Evaluate the Tolerability, Pharmacokinetics and Pharmacodynamics of Proximod in Healthy Subjects and Patients With Rheumatoid Arthritis.
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
Use of Tocilizumab Drug Levels to Optimize Treatment in RA : Concentration-guided Dose Reduction Versus Standard Dosing in Tocilizumab-treated Rheumatoid Arthritis Patients: a Randomised, Multicenter, Non-inferiority Trial (TODORA)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
Adalimumab Drug Optimisation in Rheumatoid Arthritis Using Therapeutic Drug Monitoring : Adalimumab Drug Optimisation in Rheumatoid Arthritis Using Therapeutic Drug Monitoring (ADDORA): Multi-centre Open Label Randomised Controlled Trail
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[245]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Medienart: E-Ressourcen
Filter aufheben
Zeitschrift: ClinicalTrials.gov
Medienart
2.444
Aufsätze
2.444
E-Artikel
E-Ressourcen
Zeitschriftentitel
ClinicalTrials.gov
Thema
2.444
610
2.427
Arthritis, Rheumatoid
2.408
Arthritis
1.716
Study Type: Interventional
1.567
Recruitment Status: Completed
1.252
Medical Condition: Rheumatoid Arthritis
702
Study Type: Observational
369
Phase: Phase 3
364
Phase: Phase 2
282
Recruitment Status: Recruiting
261
Phase: Phase 4
237
Phase: Phase 1
196
Medical Condition: Arthritis, Rheumatoid
182
Recruitment Status: Terminated
163
Recruitment Status: Unknown status
92
Recruitment Status: Active, not recruiting
89
Recruitment Status: Not yet recruiting
77
Arthritis, Psoriatic
73
Spondylitis
72
Osteoarthritis
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
987
2020-
1.358
2010-2019
99
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
2.444
Englisch
Haven't found what you're looking for?
Wird geladen...